GG-derived geranylgeranylacetone has been shown to mitigate depression-associated behaviors in the forced swim and tail suspension tests in a chronic mild stress mouse model of depression via the suppression of monoamine oxidase-A expression [35]. This evidence concerns the gene MAOA and depressive symptom measurement.